Christopher M. Poole
Christopher M. Poole has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Gholipour
Imaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia
1 shared publication - Brad Dolman
Department of Climate Change, Energy, The Environment and Water, Environmental Crime Section, Gadigal Country, Sydney, NSW 2000, Australia
1 shared publication - Brendan E. Allman
Rapiscan Systems Ltd., Homebush, Sydney, NSW 2041, Australia
1 shared publication - Daniele Pelliccia
Instruments & Data Tools Pty Ltd
1 shared publication - Debashish Mazumder
Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia
1 shared publication - Ha Tran Hong Phan
Rapiscan Systems Ltd., Homebush, Sydney, NSW 2041, Australia
1 shared publication
Latest Publications
- Open Access
Detect and Trace: An Australian Field Trial Using Machine-Learning Tools to Combat Illegal Wildlife Trade
The illegal wildlife trade is a global problem that continues to harm individuals, wildlife populations, ecosystems, and humans at an increasing rate. While efforts are underway globally to address the issue through a coordinated approach, the testing of new technologies in real-world settings remains limited. Here, we present the outcomes of an opportunistic Australian trial that tested two machine-learning tools during real-world seizures, including associated radiation-exposure safety data. During the seven-month trial, 116 animals were intercepted, representing reptiles and crustacea across five Genera: Tiliqua, Egernia, Oedura, Chelodina, and Euastacus. Of the 18 seized consignments, totalling 48 parcels, scanned through the RTT®110 CT X-ray baggage scanner, automated AI detected smuggled wildlife 56% of the time using the most successful algorithm (AT.3), and captured 48 high-resolution 3D X-ray images, which allowed identification of concealed wildlife. In addition, 33 Tiliqua sp. were scanned using the Olympus Vanta pXRF and the data analysed using previously published machine-learning provenance models. Common blue-tongue lizards (Tiliqua scincoides) were less likely to be wild-caught than shingleback lizards (Tiliqua rugosa). Alongside expert statements, provenance results were provided to enforcement agencies. Following the trial, there was a significant reduction in the number of seized parcels being exported through postal pathways. This trial demonstrates the impact of integrating new technology to support intelligence-led enforcement processes and reduce wildlife trafficking.
Open AccessDetect and Trace: An Australian Field Trial Using Machine-Learning Tools to Combat Illegal Wildlife Trade
The illegal wildlife trade is a global problem that continues to harm individuals, wildlife populations, ecosystems, and humans at an increasing rate. While efforts are underway globally to address the issue through a coordinated approach, the testing of new technologies in real-world settings remains limited. Here, we present the outcomes of an opportunistic Australian trial that tested two machine-learning tools during real-world seizures, including associated radiation-exposure safety data. During the seven-month trial, 116 animals were intercepted, representing reptiles and crustacea across five Genera: Tiliqua, Egernia, Oedura, Chelodina, and Euastacus. Of the 18 seized consignments, totalling 48 parcels, scanned through the RTT®110 CT X-ray baggage scanner, automated AI detected smuggled wildlife 56% of the time using the most successful algorithm (AT.3), and captured 48 high-resolution 3D X-ray images, which allowed identification of concealed wildlife. In addition, 33 Tiliqua sp. were scanned using the Olympus Vanta pXRF and the data analysed using previously published machine-learning provenance models. Common blue-tongue lizards (Tiliqua scincoides) were less likely to be wild-caught than shingleback lizards (Tiliqua rugosa). Alongside expert statements, provenance results were provided to enforcement agencies. Following the trial, there was a significant reduction in the number of seized parcels being exported through postal pathways. This trial demonstrates the impact of integrating new technology to support intelligence-led enforcement processes and reduce wildlife trafficking.
- Open Access
- 18 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (22) , 2590
Four-Dimensional Flow MRI for Cardiovascular Evaluation (4DCarE): A Prospective Non-Inferiority Study of a Rapid Cardiac MRI Exam: Study Protocol and Pilot Analysis
Background: Accurate measurements of flow and ventricular volume and function are critical for clinical decision-making in cardiovascular medicine. Cardiac magnetic resonance (CMR) is the current gold standard for ventricular functional evaluation but is relatively expensive and time-consuming, thus limiting the scale of clinical applications. New volumetric acquisition techniques, such as four-dimensional flow (4D-flow) and three-dimensional volumetric cine (3D-cine) MRI, could potentially reduce acquisition time without loss in accuracy; however, this has not been formally tested on a large scale. Methods: 4DCarE (4D-flow MRI for cardiovascular evaluation) is a prospective, multi-centre study designed to test the non-inferiority of a compressed 20 min exam based on volumetric CMR compared with a conventional CMR exam (45–60 min). The compressed exam utilises 4D-flow together with a single breath-hold 3D-cine to provide a rapid, accurate quantitative assessment of the whole heart function. Outcome measures are (i) flow and chamber volume measurements and (ii) overall functional evaluation. Secondary analyses will explore clinical applications of 4D-flow-derived parameters, including wall shear stress, flow kinetic energy quantification, and vortex analysis in large-scale cohorts. A target of 1200 participants will enter the study across three sites. The analysis will be performed at a single core laboratory site. Pilot Results: We present a pilot analysis of 196 participants comparing flow measurements obtained by 4D-flow and conventional 2D phase contrast, which demonstrated moderate–good consistency in ascending aorta and main pulmonary artery flow measurements between the two techniques. Four-dimensional flow underestimated the flow compared with 2D-PC, by approximately 3 mL/beat in both vessels. Conclusions: We present the study protocol of a prospective non-inferiority study of a rapid cardiac MRI exam compared with conventional CMR. The pilot analysis supports the continuation of the study. Study Registration: This study is registered with the Australia and New Zealand Clinical Trials Registry (Registry number ACTRN12622000047796, Universal Trial Number: U1111-1270-6509, registered 17 January 2022—Retrospectively registered).
- 18 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (22) , 2590
Open AccessFour-Dimensional Flow MRI for Cardiovascular Evaluation (4DCarE): A Prospective Non-Inferiority Study of a Rapid Cardiac MRI Exam: Study Protocol and Pilot Analysis
Background: Accurate measurements of flow and ventricular volume and function are critical for clinical decision-making in cardiovascular medicine. Cardiac magnetic resonance (CMR) is the current gold standard for ventricular functional evaluation but is relatively expensive and time-consuming, thus limiting the scale of clinical applications. New volumetric acquisition techniques, such as four-dimensional flow (4D-flow) and three-dimensional volumetric cine (3D-cine) MRI, could potentially reduce acquisition time without loss in accuracy; however, this has not been formally tested on a large scale. Methods: 4DCarE (4D-flow MRI for cardiovascular evaluation) is a prospective, multi-centre study designed to test the non-inferiority of a compressed 20 min exam based on volumetric CMR compared with a conventional CMR exam (45–60 min). The compressed exam utilises 4D-flow together with a single breath-hold 3D-cine to provide a rapid, accurate quantitative assessment of the whole heart function. Outcome measures are (i) flow and chamber volume measurements and (ii) overall functional evaluation. Secondary analyses will explore clinical applications of 4D-flow-derived parameters, including wall shear stress, flow kinetic energy quantification, and vortex analysis in large-scale cohorts. A target of 1200 participants will enter the study across three sites. The analysis will be performed at a single core laboratory site. Pilot Results: We present a pilot analysis of 196 participants comparing flow measurements obtained by 4D-flow and conventional 2D phase contrast, which demonstrated moderate–good consistency in ascending aorta and main pulmonary artery flow measurements between the two techniques. Four-dimensional flow underestimated the flow compared with 2D-PC, by approximately 3 mL/beat in both vessels. Conclusions: We present the study protocol of a prospective non-inferiority study of a rapid cardiac MRI exam compared with conventional CMR. The pilot analysis supports the continuation of the study. Study Registration: This study is registered with the Australia and New Zealand Clinical Trials Registry (Registry number ACTRN12622000047796, Universal Trial Number: U1111-1270-6509, registered 17 January 2022—Retrospectively registered).